| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1500051 | 重组人源化抗VEGF单克隆抗体注射液 | Injection | Biological Products(2) | New Drug Application | 2016-05-03 | 上海康岱生物医药技术股份有限公司 | Shanghai Kanda BIO-TECHNOLOGY Co Ltd | Certificate Issued | 2017-08-21 | view | |
| CXSB2000020 | KD6001注射液 | KD6001 | Injection | Biological Products | Supplementary Application | 2020-06-28 | 上海康岱生物医药技术股份有限公司 | Shanghai Kanda BIO-TECHNOLOGY Co Ltd | In Review | 2020-06-24 | view |
| CXSL1900131 | KD6001注射液 | KD6001 | Injection | Biological Products(1) | New Drug Application | 2019-11-23 | 上海康岱生物医药技术股份有限公司 | Shanghai Kanda BIO-TECHNOLOGY Co Ltd | In Review | 2019-11-22 | view |